人类脏活检中的TIMP-2和IGFBP7在脏疾病中
Moritz Schanz1, Martin Kimmel2, Mark Dominik Alscher1
1Department of Internal Medicine, Division of General Internal Medicine and Nephrology, Robert-Bosch Hospital Stuttgart, Germany.
Clinical kidney journal
|September 4, 2023
概括
基因金属蛋白酶-2 (TIMP-2) 的组织抑制剂和胰岛素样生长因子结合蛋白7 (IGFBP7) 在患病的脏组织中表达的增加,特别是在管道中. 这些标志物与损伤相关,支持在急性损伤风险评估中使用它们.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物标志物发现发现
- 脏病理学 脏病理学
背景情况:
- 基因金属蛋白酶-2 (TIMP-2) 的组织抑制剂和胰岛素样生长因子结合蛋白7 (IGFBP7) 是急性损伤风险的已确立尿路生物标志物.
- 人类病组织中TIMP-2和IGFBP7的表达特征和局部化尚未得到充分研究.
研究的目的:
- 为了研究TIMP-2和IGFBP7的表达和局部化在人类脏活检中,确认了脏疾病.
- 为了将这些标记物的表达与脏疾病中的组织病理学发现相关联.
主要方法:
- 分析了37例脏活检,这些活检来自患有脏疾病的患者和10例使用免疫组织化学检测TIMP-2和IGFBP7.7的对照人群.
- 质硬化 (GSI) 和管管损伤 (TSI) 的半定量评分.
- 使用班夫分类对间歇性纤维化和管状缩 (IF/TA) 的分类.
主要成果:
- 与对照人群相比,患病脏的TIMP-2和IGFBP7表达显著更高,主要是在管状区.
- IGFBP7局限于近端和远端管道;TIMP-2局限于收集管道.
- 损伤得分 (GSI,STI) 与TIMP-2和IGFBP7染色强度相关.
结论:
- TIMP-2和IGFBP7作为损伤的非特异性标志物.
- 这些发现支持尿道TIMP-2/IGFBP7在早期急性损伤检测中的确定的作用.
相关概念视频
Acute Kidney Injury II: Pathophysiology
26
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
26
Kidney Transplant I: Introduction
28
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
28


